Hypertriglyceridemia in New-Onset Type 1 Pediatric Diabetes

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Diabetes Mellitus

Background:

• Hypertriglyceridemia (HTG) is common in new-onset diabetes due to insulin deficiency.
• Severe HTG (TG > 1000 mg/dL) in pediatric patients with new-onset type 1 diabetes (T1D) is rare and poorly characterized.
• Insulin deficiency impairs triglyceride clearance and promotes lipolysis.

Purpose of the Study:

• To characterize the incidence and sequelae of severe HTG in pediatric patients with new-onset T1D.
• To review a single-center experience and literature cases of severe HTG in this population.
• To discuss potential screening and monitoring strategies.

Main Methods:

• Retrospective review of a single-center experience (2013-2022).
• Literature search for previously reported cases of severe HTG in pediatric new-onset T1D.
• Analysis of patient presentations, TG levels, and associated complications.

Main Results:

• Severe HTG in pediatric new-onset T1D is rare but presents with variable clinical manifestations.
• Cases were associated with high-risk complications, including acute pancreatitis.
• The true incidence and long-term sequelae require further investigation.

Conclusions:

• Severe HTG in pediatric new-onset T1D, though rare, necessitates clinical attention due to potential complications.
• Early screening for HTG and pancreatitis is suggested for pediatric patients with new-onset T1D and prolonged abdominal pain.
• Close monitoring of pediatric patients identified with significant HTG is recommended.